#Avian Influenza Vaccines Market Share
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
Forty percent of Tumblr users are between the ages of 18 to 25.
Link
0 notes
Text
Poultry Vaccination—a Perusal of Diseases Control Measures Based on Regions and Countries
The high-density rearing of commercial birds has put the spotlight on poultry vaccination to boost immunity and protect against strains of pathogens. The prevalence of Newcastle diseases among turkeys, ducks, birds, geese and guinea fowl has prompted several countries to bolster their policies. In essence, Victoria, Australia, has made vaccination for Newcastle disease mandatory. Besides, pervasive antibiotic resistant salmonella strains in South Africa were reported in South Africa in 2022. The U.S., meanwhile, reported 57.53 million poultry animals grappling with high pathogenic avian influenza (HPAI), as of December 2022.
Grand View Research’s Animal Health Research Team has collated a qualitative and quantitative database with an emphasis on 3 key poultry diseases across 23 countries. The final report, coupled with the database, will deep-dive into the following dynamics:
• Estimated total poultry population with inputs on disease- status and –prevalence, reported new outbreaks, official vaccination and government regulations, among others.
• Insights on control measures, including general surveillance, border precaution, movement control and disease notification.
• Trends that could play an invaluable role in shaping the regional outlook, including North America, Europe and Asia Pacific.
• The database will also shed some light on government initiatives, vaccination status, disease status and reported new outbreaks.
Get your copy or request a free sample of the report “Poultry Vaccination Coverage Estimation By Diseases, 2018 – 2021,” compiled and published by Grand View Research.
Poultry Vaccination Coverage Report Scope
Species: Poultry
Region: North America, Europe, Asia Pacific, LATAM, MEA Country: U.S., Canada, UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, China, Japan, India, Australia, Thailand, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, Kuwait
Total Animal Population: Estimated Total Poultry Population from 2018 to 2021 (in numbers)
Disease Type: Newcastle Disease, Salmonella Sp., Avian Influenza-HPAI
Estimated Vaccination Coverage in %: Specifies the estimated percentage of animals that have received vaccination (at least one vaccine dose) for that particular disease. Includes both prophylactic and therapeutic vaccination.
Years: Quantitative Data 2018; 2019; 2020; 2021 Qualitative Data includes the 2022 updates
Notes: Specifies the relevant information on disease prevalence, disease active/non-active status, control measures, vaccination status (official/prohibited), reported new outbreaks for the years in scope, prevalent serotypes of viruses, recent disease situational updates, government initiatives, and others.
Deliverable Format: MS Excel/ Dashboard
Related Reports:
• Poultry Vaccines Market Size, Share & Trends Analysis Report By Product (Attenuated Live Vaccines, Inactivated Vaccines, Recombinant Vaccines), By Disease Type, By Application, By Region, And Segment Forecasts, 2023 – 2030
• ASEAN Poultry Vaccines Market Size, Share & Trends Analysis Report By Product (Attenuated Live Vaccines, Inactivated Vaccines, DNA Vaccines), By Application, By Disease, By Country, And Segment Forecasts, 2023 - 2030
About Us
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.
Find More information @ https://www.grandviewresearch.com/info/trend-reports
#Poultry vaccine companies#Poultry Vaccination Coverage#Poultry Vaccination Market#Poultry Vaccination Industry
0 notes
Text
0 notes
Text
Avian Influenza Vaccines Market Size, Share, Economic Growth, Emerging Trends and Forecast till 2031
The report extensively examines the global Avian Influenza Vaccines market while focusing on the leading companies and their business strategies, geographical growth, market segmentation, competitive environment, production, price, and cost structures. Each section of the research report has been carefully designed to examine important facets of the global market for Avian Influenza Vaccines. For instance, the market dynamics section delves deeply into the trends, opportunities, and drivers influencing the global market for Avian Influenza Vaccines . We assist you with full and extensive research on the global Avian Influenza Vaccines Market using qualitative and quantitative analysis. Additionally, we concentrated on SWOT, PESTLE, and Porter's Five Forces assessments of the worldwide market for Avian Influenza Vaccines .
Get Sample Report With Graphs and Table @ https://www.growthplusreports.com/inquiry/request-sample/avian-influenza-vaccines-market/8566
Key Players Mentioned in the Global Avian Influenza Vaccines Market Research Report:
QianYuanHao Biological Corporation Limited
Bayer AG
Ringpu Bio-Technology Co., Ltd.
Harbin Veterinary Research Institute
Elanco
Zoetis Inc.
Eli Lilly and Company
FATRO S.p.A.
Johnson & Johnson Private Limited
Merck Animal Health
Boehringer Ingelheim GmbH
SEGMENTS
GLOBAL AVIAN INFLUENZA VACCINES MARKET - ANALYSIS & FORECAST, BY TYPE
Combination Vaccines
Inactivated Vaccines
Live Recombinant Vaccines
GLOBAL AVIAN INFLUENZA VACCINES MARKET - ANALYSIS & FORECAST, BY STRAIN
H5 Strain
H7 Strain
H9 Strain
GLOBAL AVIAN INFLUENZA VACCINES MARKET - ANALYSIS & FORECAST, BY APPLICATION
Chicken
Turkey
Duck
Goose
Finding dominant companies in a specific Avian Influenza Vaccines industry is only one aspect of an analyst's role. To produce a thorough and comprehensive Avian Influenza Vaccines research study, analysts put out significant work, invest hours in research and analysis, compile unique information from market specialists, and draw on their own expertise and knowledge of the sector. One of a market research report's most crucial sections is the company profiling section since it offers players essential information they can use to improve their businesses or move them forward. In addition to identifying the leading companies in the global market for Avian Influenza Vaccines , this study also examines important facets of each company's operations and presents market growth estimates.
Avian Influenza Vaccines Market TOC: https://www.growthplusreports.com/report/toc/avian-influenza-vaccines-market/8566
Avian Influenza Vaccines Market: Regional analysis includes
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
For More Information or Query or Customization before buying, Visit at: https://www.growthplusreports.com/inquiry/customization/avian-influenza-vaccines-market/8566
Reasons to Buy This Report:
This file will help the peruses with appreciation the opposition interior the ventures and structures for the serious local weather to improve the feasible benefit. The document moreover facilities round the cutthroat scene of the market, and provides exhaustively the piece of the pie, industry positioning, contender organic system, market execution, new object advancement, recreation circumstance, development, and securing.
And so forth of the fundamental players, which assists the peruses with distinguishing the indispensable contenders and profoundly know the opposition instance of the market.
This record will help companions with greedy the global enterprise popularity and patterns of Avian Influenza Vaccines Administration Frameworks and offers them statistics on key market drivers, restrictions, difficulties, and open doors.
This document will aid companions with grasp contenders higher and collect experiences to reinforce their scenario in their organizations. The serious scene region contains the piece of the pie and rank (in extent and worth), contender environment, new object improvement, development, and obtaining.
This document stays refreshed with novel innovation mix, highlights, and the latest developments on the lookout.
This file assists companions with grasp the Coronavirus and Russia-Ukraine War Impact on the Avian Influenza Vaccines Administration Frameworks industry.
This record assists companions with obtaining bits of know-how into what locales to internationally target.
This file assists companions with obtaining experiences into the end-client perception regarding the reception of Avian Influenza Vaccines Administration Frameworks.
This document assists companions with distinguishing a component of the central members on the lookout and hold close their essential commitment.
Purchase this report now at 20% flat discount @ https://www.growthplusreports.com/checkout-8566
Visit our report store at - https://www.growthplusreports.com/report-store
Manan Sethi
Director, Market Insights
Email: [email protected]
256 Chapman Road
STE 105-4, Newark,
New Castle - 19702, USA
Phone no: +1 888 550 5009
Web: https://www.growthplusreports.com/
About US
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020."
0 notes
Link
0 notes
Text
Avian Influenza Vaccines Market Size, Share, Growth Opportunity and Trends by Growing CAGR till 2026
The global Avian Influenza Vaccines Market research report 2021 available on DecisionDatabases covers top company players in various countries along with analyzing the market trends and growth rate. Segment analysis by types and application helps in bifurcating the Avian Influenza Vaccines market and understand each product type. This report provides information on various market factors such as market size, share, manufacturer's data, growth, and forecast till 2026.
The key market players for the global Avian Influenza Vaccines market are listed below:
Merial
Elanco (Lohmann )
CEVA
Zoetis
Avimex Animal Health
Merck Animal Health
Others
Click here to get a FREE Sample Copy of the Avian Influenza Vaccines Market Research Report @ https://www.decisiondatabases.com/contact/download-sample-26898
The Global Avian Influenza Vaccines Market Report is equipped with market data from 2016 to 2026. The report gives a market overview covering key drivers and risk factors. The report is bifurcated by top global manufactures mentioning sales, revenue, and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2021 to 2026. The detailed sales channel is also covered in the study.
COVID-19 Impact Analysis on Avian Influenza Vaccines Market
The global pandemic COVID-19 has affected the Avian Influenza Vaccines market directly or indirectly. This study covers a separate section giving an explicitly clear understanding of the aftereffects of this pandemic. The detailed study highlights the probable outcomes of this global crisis on the Avian Influenza Vaccines industry. The impact study on production, supply-demand, and sales provides a holistic approach to the future.
Do You Have Any Query Or Report Customization? Ask Our Market Expert @ https://www.decisiondatabases.com/contact/ask-questions-26898
Why Purchase this Report?
A robust research methodology has been followed to collect data for the report. Data, thus collected passes through multiple quality checks to ensure the best quality is served.
The report gives a holistic view of the competitive scenario of the Avian Influenza Vaccines market
The latest product launches along with technological changes and development are covered in the report.
The data analysis in the report helps in understanding the anticipated Avian Influenza Vaccines market dynamics from 2021 to 2026.
DecisionDatabases has a vast repository of data, therefore, we can accommodate customized requirements also.
The graphs, tables and pie charts, and info-graphics covered in the report will help in a better understanding of the report.
The market drivers, restraints, upcoming opportunities, and anticipated restraints cited in the report will assist in making an informed decision.
To better understand the market scenario, the Avian Influenza Vaccines market is segmented as below:
By Types:
Type H5
Type H9
Other
By Applications:
Chicken
Duck & Goose
Other
By Regions:
North America (U.S., Canada, Mexico)
Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)
Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
Latin America (Brazil, Rest of L.A.)
The Middle East and Africa (Turkey, GCC, Rest of Middle East)
The content of the study subjects includes a total of 14 chapters:
Chapter 1: To describe Avian Influenza Vaccines product scope, market overview, market opportunities, market driving force, and market risks. Chapter 2: To profile the top manufacturers of Avian Influenza Vaccines, with price, sales, revenue, and global market share of Avian Influenza Vaccines in 2018 and 2019. Chapter 3: The Avian Influenza Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4: The Avian Influenza Vaccines breakdown data are shown at the regional level, to show the sales, revenue, and growth by region, from 2015 to 2020. Chapter 5 and 6: To segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020. Chapter 7, 8, 9, 10 & 11: To break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2016 to 2021 and Avian Influenza Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2021 to 2026. Chapter 12, 13 & 14: To describe Avian Influenza Vaccines sales channel, distributors, customers, research findings and conclusion, appendix, and data source.
Directly Purchase the Complete Global Avian Influenza Vaccines Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-26898
About Us:
DecisionDatabases.com is a global business research report provider, enriching decision-makers, and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research reports, customized research reports, company profiles, and industry databases across multiple domains. Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise, and meaningful data at a lightning speed.
For more details: DecisionDatabases.com E-Mail: [email protected] Phone: +91 90 28 057900 Web: https://www.decisiondatabases.com/
#Avian Influenza Vaccines Market#Avian Influenza Vaccines Market Report#Avian Influenza Vaccines Market Size#Avian Influenza Vaccines Market Share
0 notes
Text
Global Avian Influenza Vaccines Market Trends, Drivers, Strategies, Applications and Competitive Landscape 2023
Global Avian Influenza Vaccines Market Trends, Drivers, Strategies, Applications and Competitive Landscape 2023
Global Avian Influenza Vaccines marketreport offers in-depth knowledge and analysis results and knowledge concerning Avian Influenza Vaccines drivers, restraints, opportunities, and trends valid by a mixture of specialists with correct data of the precise trade and Avian Influenza Vaccines market further as region-wise analysis experience. The Avian Influenza Vaccines report contains historical,…
View On WordPress
#Avian Influenza Vaccines Market Analysis#Avian Influenza Vaccines Market drivers#Avian Influenza Vaccines Market Share#Avian Influenza Vaccines Market Trends#Global Avian Influenza Vaccines Market 2018 Forecast
0 notes
Text
Animal Vaccines Market Report, Growth Insight, Deep Research & Segment Analysis 2027
Market Highlights
The global animal vaccines market is expected to have a market value of USD 13,209.14 million by 2027.
The animal vaccines market suffered immensely because pet owners and farmers were encouraged to keep their animals at home. They were advised against taking their pets to the vet to get strong and effective vaccines like the Pfizer veterinary vaccines. Growth in the veterinary/animal vaccines market is starting to pick up dramatically now that a vaccine for COVID-19 is being widely administered. Demand for animal vaccines is surging because livestock on farms around the world need these to remain healthy Segment Analysis
The global animal vaccines market is segmented into type, technology, and region. The type segment is further segmented into porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquacultutre vaccines. The technology segment is segmented into Live attenuated vaccines, Inactivated vaccines, Toxoid vaccines, Recombinant vaccines, others.
Regional Analysis
The global palliative care market, based on region, has been divided into Americas, Europe, Asia-Pacific, and Middle East & Africa.
Americas dominated the global animal vaccine market due to various factors, such as the rising prevalence of animal diseases and the rise in pet ownership in the region. Furthermore, the high number of veterinary clinics in the region also boosts the growth of the market. There is an increasing prevalence of animal diseases such as foot & mouth disease, canine parvovirus, distemper, and reproductive & respiratory syndrome. Parvovirus infections are seen across the US and Canada. The American Veterinary Medical Association (AVMA) reported around 118,624 veterinary practitioners were operating in 2020. Similarly, according to the statistics published by the Canadian Veterinary Medical Association in 2020, about 12,921 veterinarians were present in Canada.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7184
Europe accounted for a significant share in the market owing to a high population of companion animals in Europe, rising research and development investment, and increasing adoption of animal vaccines. According to the Industrial Association of Pet Care Producers, there are around 34 million pets in the UK, including dogs, cats, small mammals, and birds. In October 2021, Boehringer Ingelheim announced an additional 100 million EUR investment in its veterinary public health capabilities in Lyon-Jonage, France, to aid governments and public health organizations in managing future emerging and transboundary diseases. The additional investment will enable the adaptation of production lines for other emerging diseases, in particular swine and avian vaccines.
Asia-Pacific is expected to exhibit the highest CAGR during the forecast period of 2021-2027. This is due to lucrative opportunities for players operating in the animal vaccine market, a rise in the livestock population, and the increasing prevalence of animal diseases in the region. There is increasing awareness about animal health in the Asia-Pacific region. For instance, according to the report published by Pet Fair Asia and goumin.com, the total number of pet dogs and cats in China reached 99.15 million, with pet owners spending 29 billion US dollars in 2019. The increasing prevalence of animal diseases such as foot and mouth disease and avian influenza boosts the market growth in the region.
Middle East & Africa is expected to witness restricted growth compared to other regions due to limited access and healthcare affordability. The market growth in the region is driven by factors like the increasing incidence of zoonotic diseases and increasing pet adoption in the region. The common zoonotic disease diagnosed in this region is Rift Valley fever. Hence, emphasis is being put on promoting animal health in the region and improving healthcare services for companion animals.
Key Findings of the Study
The global animal vaccines market is estimated to reach USD 13,209.14 million by 2027 at a CAGR of 7.48 % during the assessment period.
Americas accounted for the largest share of the global animal vaccines market due to the rising prevalence of animal diseases and the rise in pet ownership in the region.
Based on type, the companion animal vaccines segment accounted for the largest market share of 42.2% in 2020.
By technology, the live attenuated vaccines segment accounted for the largest market share of 62.02% in 2020.
Some of the key players operating in the animal vaccines market are Boehringer Ingelheim International GmbH (Germany), Zoetis Inc. (US), Ceva Santé Animale (France), Merck & Co., Inc. (US), Elanco Animal Health Incorporated (US), Virbac (France), Phibro Animal Health Corporation (US), Hipra (Spain), Biogénesis Bagó S.A.(Argentina), Neogen Corporation (US).
Browse Detailed TOC with COVID-19 Impact Analysis at
https://www.marketresearchfuture.com/reports/animal-vaccines-market-7184
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
0 notes
Text
Impact Assessment of COVID-19 Outbreak on Veterinary Vaccines Market
The research authors at Transparency Market Research have placed the evaluation of the global veterinary vaccines market at US$ 6,100 million in the year of 2017. They predict that the global veterinary vaccines market will grow at an exemplary CAGR of 6.5% over the forecast period of 2018 to 2026 and go on to hit the mark of US$ 12,000 million by the end of the forecast period in 2026. Rising spending on companion pet animals along with increasing prevalence of various animal diseases is expected to propel the growth of global veterinary vaccines market in coming years.
Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=215
Increasing prevalence of animal diseases such as rift valley fever and rotavirus, rising utilization of different types of animal vaccines, and increasing awareness regarding the availability of different types of vaccination programs in motivating the growth of the global veterinary vaccines market in coming years. Rising prevalence of avian influenza and foot and mouth disease, considered as two of the foremost trans barrier animal diseases have also fueled the requirement for enhanced products in the global veterinary vaccines market.
Request a Sample of Veterinary Vaccines Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=215
DNA Vaccines Segment to Witness High Growth in Veterinary Vaccines Market in Near Future
Segments in the global veterinary vaccines market by technology include inactivated vaccines, live attenuated vaccines, conjugate vaccines, toxoid vaccines, and DNA Vaccines, among others. Live attenuated vaccines segment led the global veterinary vaccines market in recent years, however, this segment is projected to lose momentum owing to loss of opportunities for the new industry players in this particular segment. DNA vaccines segment may witness significant growth opportunities in the global veterinary vaccines market in coming years owing to their various advantages such as no need for adjuvants as well as no post vaccination reactions.
Segments in the global veterinary vaccines market by type of animal include companion animal vaccines and livestock animal vaccines. Livestock animal vaccines segments led the global veterinary vaccines market in 2017 but is anticipated to lose market share over the forecast period owing to decreasing number of farm animals in certain regions in the world. On the other hand, increasing number of companion animals along with rising expenditure on pet healthcare are expected to boost the segment in global veterinary vaccines market over the forecast period.
Request for Analysis of COVID19 Impact on Veterinary Vaccines Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=215
North America Region Leads the Veterinary Vaccines Market
Key geographical regions covered in the professional intelligence report on the global veterinary vaccines market include North America (Canada and United States), Asia Pacific (including China, Japan, New Zealand, India, Australia, and rest of the Asia Pacific), Europe (including the United Kingdom, France, Spain, Italy, Germany, and rest of the Europe), Middle East and Africa (including South Africa, Gulf Cooperation Council countries, Israel, and rest of the Middle East and Africa), and Latin America (including Brazil, Mexico, and rest of the Latin America). Geographically, North America region held the largest share in the global veterinary vaccines market in 2017. This position in anticipated to remain in the forecast period, owing to rising ownership of companion animals and advanced vaccination programs in the region.
Enquiry before Buying Veterinary Vaccines Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=215
Players in the Veterinary Vaccines Market Expanding their Product Portfolios
Major corporate players covered in the market analysis on global veterinary vaccines market include Merck Animal Health, Eli Lilly and Company, Ceva Santé Animale, Biovac, ImmuCell Corporation, Boehringer Ingelheim GmbH, Zoetis, Inc., Bayer Animal health AG, Virbac, and Neogen Corporation. Manufacturers and players in the global veterinary vaccines market are adopting various inorganic as well as organic growth strategies to enhance their current product offerings and expand their product portfolios in order to gain a larger market share by expanding their consumer base as well as geographical reach. For example, Prondil S.A, an Uruguayan company was acquired by Merck Animal health in December of 2017 to design and produce more advanced livestock animal vaccines.
More Trending Reports by Transparency Market Research:
https://www.prnewswire.com/news-releases/human-microbiome-market-to-reach-us-2-2-bn-by-2028--states-tmr-report-301475663.html
https://www.prnewswire.com/news-releases/increase-in-prevalence-of-fascioliasis-to-help-triclabendazole-market-reach-us-632-1-mn-by-2031--notes-tmr-study-301478857.html
https://www.prnewswire.com/news-releases/medical-transcription-services-market-to-expand-at-cagr-of-5-during-forecast-period-observes-tmr-study-301482824.html
About Us Section:
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Rohit Bhisey Transparency Market Research, 90 State Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: [email protected]
Website: https://www.transparencymarketresearch.com/
0 notes
Link
Avian Influenza Vaccine Marketresearch, Avian Influenza Vaccine Marketreport, Avian Influenza Vaccine Marketresearch report
0 notes
Text
Avian Influenza Vaccines Market Size, Share, Economic Growth, Emerging Trends and Forecast till 2031
The report extensively examines the global Avian Influenza Vaccines market while focusing on the leading companies and their business strategies, geographical growth, market segmentation, competitive environment, production, price, and cost structures. Each section of the research report has been carefully designed to examine important facets of the global market for Avian Influenza Vaccines. For instance, the market dynamics section delves deeply into the trends, opportunities, and drivers influencing the global market for Avian Influenza Vaccines . We assist you with full and extensive research on the global Avian Influenza Vaccines Market using qualitative and quantitative analysis. Additionally, we concentrated on SWOT, PESTLE, and Porter's Five Forces assessments of the worldwide market for Avian Influenza Vaccines .
Get Sample Report With Graphs and Table @ https://www.growthplusreports.com/inquiry/request-sample/avian-influenza-vaccines-market/8566
Key Players Mentioned in the Global Avian Influenza Vaccines Market Research Report:
QianYuanHao Biological Corporation Limited
Bayer AG
Ringpu Bio-Technology Co., Ltd.
Harbin Veterinary Research Institute
Elanco
Zoetis Inc.
Eli Lilly and Company
FATRO S.p.A.
Johnson & Johnson Private Limited
Merck Animal Health
Boehringer Ingelheim GmbH
SEGMENTS
GLOBAL AVIAN INFLUENZA VACCINES MARKET - ANALYSIS & FORECAST, BY TYPE
Combination Vaccines
Inactivated Vaccines
Live Recombinant Vaccines
GLOBAL AVIAN INFLUENZA VACCINES MARKET - ANALYSIS & FORECAST, BY STRAIN
H5 Strain
H7 Strain
H9 Strain
GLOBAL AVIAN INFLUENZA VACCINES MARKET - ANALYSIS & FORECAST, BY APPLICATION
Chicken
Turkey
Duck
Goose
Finding dominant companies in a specific Avian Influenza Vaccines industry is only one aspect of an analyst's role. To produce a thorough and comprehensive Avian Influenza Vaccines research study, analysts put out significant work, invest hours in research and analysis, compile unique information from market specialists, and draw on their own expertise and knowledge of the sector. One of a market research report's most crucial sections is the company profiling section since it offers players essential information they can use to improve their businesses or move them forward. In addition to identifying the leading companies in the global market for Avian Influenza Vaccines , this study also examines important facets of each company's operations and presents market growth estimates.
Avian Influenza Vaccines Market TOC: https://www.growthplusreports.com/report/toc/avian-influenza-vaccines-market/8566
Avian Influenza Vaccines Market: Regional analysis includes
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
For More Information or Query or Customization before buying, Visit at: https://www.growthplusreports.com/inquiry/customization/avian-influenza-vaccines-market/8566
Reasons to Buy This Report:
This file will help the peruses with appreciation the opposition interior the ventures and structures for the serious local weather to improve the feasible benefit. The document moreover facilities round the cutthroat scene of the market, and provides exhaustively the piece of the pie, industry positioning, contender organic system, market execution, new object advancement, recreation circumstance, development, and securing.
And so forth of the fundamental players, which assists the peruses with distinguishing the indispensable contenders and profoundly know the opposition instance of the market.
This record will help companions with greedy the global enterprise popularity and patterns of Avian Influenza Vaccines Administration Frameworks and offers them statistics on key market drivers, restrictions, difficulties, and open doors.
This document will aid companions with grasp contenders higher and collect experiences to reinforce their scenario in their organizations. The serious scene region contains the piece of the pie and rank (in extent and worth), contender environment, new object improvement, development, and obtaining.
This document stays refreshed with novel innovation mix, highlights, and the latest developments on the lookout.
This file assists companions with grasp the Coronavirus and Russia-Ukraine War Impact on the Avian Influenza Vaccines Administration Frameworks industry.
This record assists companions with obtaining bits of know-how into what locales to internationally target.
This file assists companions with obtaining experiences into the end-client perception regarding the reception of Avian Influenza Vaccines Administration Frameworks.
This document assists companions with distinguishing a component of the central members on the lookout and hold close their essential commitment.
Purchase this report now at 20% flat discount @ https://www.growthplusreports.com/checkout-8566
Visit our report store at - https://www.growthplusreports.com/report-store
Manan Sethi
Director, Market Insights
Email: [email protected]
256 Chapman Road
STE 105-4, Newark,
New Castle - 19702, USA
Phone no: +1 888 550 5009
Web: https://www.growthplusreports.com/
About US
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020."
0 notes
Text
Influenza Diagnostics Market Expected To Cross $3.3 Billion By 2024
The influenza diagnostics market is expected to reach USD 3.3 billion by 2024, according to a new report by Grand View Research, Inc. Influenza, or "the flu," is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on public health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. The growth in the influenza diagnostic market is attributed to factors such as emergence of technologically advanced diagnostic tests with shorter turnaround time; initiatives by regulatory bodies, such as CDC’s seasonal influenza vaccination for prevention and control of seasonal influenza; and the demand created for influenza diagnosis in the flu season.
Rapid Influenza Diagnostic Tests (RIDTs) accounted for the largest share in 2015. RIDTs are tests that deliver accurate results in approximately 15 minutes. This factor deems them efficient, which has resulted in the lucrative growth of this segment with the fastest CAGR. Reverse transcription polymerase chain reaction (RT-PCR) holds the second highest market share following RIDTs, and this can be attributed to the fact that it provides detailed analytical results, sharper turnaround times, and high throughput.
Hospitals held the highest market share in 2015, but Point-of-Care Testing (POCT) is anticipated to overtake and lead the market in the coming future, owing to the increasing usage of POCT because of its ease of use and short turnaround times.
North America dominates the market, due to a high focus of the government and healthcare bodies to control influenza.
To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/influenza-diagnostics-market
Further Key Findings From the Study Suggest:
North America is anticipated to dominate the global influenza diagnostics market. The high adoption rates of in vitro diagnostics and presence of technologically advanced medical devices is expected to drive growth in the region.
The Asia Pacific region is anticipated to be the fastest growing region in the study period. This growth is attributed to factors such as increasing initiatives by the countries to counter the incidence of the disease. For instance, CDC reached a cooperative agreement with South-East Asian Region to fund non research-related bilateral influenza as a measure to respond to avian, seasonal, and pandemic influenza.
The RIDT segment is expected to grow at a significant rate compared to others and accounts for the largest share in 2015.
This market comprises several local as well as global players. Some of the major players of this vertical include Becton, Dickinson and Company, Roche Diagnostics, Alere, Quidel Corporation, and Thermo Fisher Scientific.
Grand View Research has segmented the influenza diagnostics market on the basis of test type, end use, and region:
Test Type Outlook (Revenue, USD Million, 2013 - 2024)
RIDTs
RT-PCR
Cell Culture
Others
End-use Outlook (Revenue, USD Million, 2013 - 2024)
Hospital
Point-of-Care Testing
Laboratories
Regional Outlook (Revenue, USD Million, 2013 - 2024)
North America
Europe
Asia Pacific
Latin America
MEA
U.S.
Canada
Germany
UK
China
India
Brazil
Mexico
South Africa
Saudi Arabia
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
0 notes
Text
Avian Influenza Vaccines Market Size, Share, Growth Opportunity and Trends by Growing CAGR till 2026
The global AAvian Influenza Vaccines Market research report 2021 available on DecisionDatabases covers top company players in various countries along with analyzing the market trends and growth rate. Segment analysis by types and application helps in bifurcating the Avian Influenza Vaccines market and understand each product type. This report provides information on various market factors such as market size, share, manufacturer's data, growth, and forecast till 2026.
The key market players for the global Avian Influenza Vaccines market are listed below:
Merial
Elanco (Lohmann )
CEVA
Zoetis
Avimex Animal Health
Merck Animal Health
Others
Click here to get a FREE Sample Copy of the Avian Influenza Vaccines Market Research Report @ https://www.decisiondatabases.com/contact/download-sample-26898
The Global Avian Influenza Vaccines Market Report is equipped with market data from 2016 to 2026. The report gives a market overview covering key drivers and risk factors. The report is bifurcated by top global manufactures mentioning sales, revenue, and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2021 to 2026. The detailed sales channel is also covered in the study.
COVID-19 Impact Analysis on Avian Influenza Vaccines Market
The global pandemic COVID-19 has affected the Avian Influenza Vaccines market directly or indirectly. This study covers a separate section giving an explicitly clear understanding of the aftereffects of this pandemic. The detailed study highlights the probable outcomes of this global crisis on the Avian Influenza Vaccines industry. The impact study on production, supply-demand, and sales provides a holistic approach to the future.
Do You Have Any Query Or Report Customization? Ask Our Market Expert @ https://www.decisiondatabases.com/contact/ask-questions-26898
Why Purchase this Report?
A robust research methodology has been followed to collect data for the report. Data, thus collected passes through multiple quality checks to ensure the best quality is served.
The report gives a holistic view of the competitive scenario of the Avian Influenza Vaccines market
The latest product launches along with technological changes and development are covered in the report.
The data analysis in the report helps in understanding the anticipated Avian Influenza Vaccines market dynamics from 2021 to 2026.
DecisionDatabases has a vast repository of data, therefore, we can accommodate customized requirements also.
The graphs, tables and pie charts, and info-graphics covered in the report will help in a better understanding of the report.
The market drivers, restraints, upcoming opportunities, and anticipated restraints cited in the report will assist in making an informed decision.
To better understand the market scenario, the Avian Influenza Vaccines market is segmented as below:
By Types:
Type H5
Type H9
Other
By Applications:
Chicken
Duck & Goose
Other
By Regions:
North America (U.S., Canada, Mexico)
Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)
Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
Latin America (Brazil, Rest of L.A.)
The Middle East and Africa (Turkey, GCC, Rest of Middle East)
The content of the study subjects includes a total of 14 chapters:
Chapter 1: To describe Avian Influenza Vaccines product scope, market overview, market opportunities, market driving force, and market risks. Chapter 2: To profile the top manufacturers of Avian Influenza Vaccines, with price, sales, revenue, and global market share of Avian Influenza Vaccines in 2018 and 2019. Chapter 3: The Avian Influenza Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4: The Avian Influenza Vaccines breakdown data are shown at the regional level, to show the sales, revenue, and growth by region, from 2015 to 2020. Chapter 5 and 6: To segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020. Chapter 7, 8, 9, 10 & 11: To break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2016 to 2021 and Avian Influenza Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2021 to 2026. Chapter 12, 13 & 14: To describe Avian Influenza Vaccines sales channel, distributors, customers, research findings and conclusion, appendix, and data source.
Directly Purchase the Complete Global Avian Influenza Vaccines Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-26898
About Us:
DecisionDatabases.com is a global business research report provider, enriching decision-makers, and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research reports, customized research reports, company profiles, and industry databases across multiple domains. Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise, and meaningful data at a lightning speed.
For more details: DecisionDatabases.com E-Mail: [email protected] Phone: +91 90 28 057900 Web: https://www.decisiondatabases.com/
#Avian Influenza Vaccines Market#Avian Influenza Vaccines Market Report#Avian Influenza Vaccines Market Size#Avian Influenza Vaccines Market Share
0 notes
Text
[PDF] Plant-based Vaccines Market Continues to Expand Effective Alternative to Conventional Vaccines
Various studies are being conducted on plant-based vaccines as a cheap alternative to the conventional vaccine in terms of efficiency, production time, and immune system. The market players, and rising number of start-ups and research institutes are focused on R&D activities to develop treatment therapies for various infectious disease indications such as flu, dengue, norovirus, and avian influenza H5N1; based on new plant-based source vaccine. For instance, in August 2018, researchers from Arizona State University’s (ASU) Biodesign Institute developed a norovirus vaccine from tobacco plant. Genetic engineering allowed researchers to transfer specific genes from tobacco plant in designing plant-based vaccine for norovirus. Plant-based vaccine is safe and effective for use against various infectious diseases, as it activates patient’s immune system. In June 2018, researchers from the University of Nottingham, Malaysia, announced a project to develop plant-based vaccine for treatment of dengue fever caused by Aedes genus mosquitoes.
Download Exclusive Sample Report (350 Pages PDF with All Related Graphs & Charts) @ https://www.coherentmarketinsights.com/insight/request-sample/2004
By using tobacco plant, researchers were successful in producing vaccine antigen that has the capability to neutralize dengue virus. Moreover, vaccines produced through plant sources provide a new platform to produce vaccines that can be orally administered rather than intravenously, which is the route of administration for most of the currently available vaccines. Researchers are also conducting research on edible plant species such as lettuce for production of vaccines in the near future. Successful completion of research studies are expected to help in developing safe and cost effective treatment to prevent dengue. For instance, according to the Journal of Botany: March 2016, the dengue virus vaccine targeting dengue-3 serotype polyprotein (DENV3prM/E) was produced in Lactuca sativa (lettuce) through a chloroplast transformation. It is further concluded that lettuce is an excellent host for agroinfiltration with deconstructed viral vectors.
Major players operating in the global plant-based vaccines market are adopting inorganic growth strategies such as collaboration and acquisition to expand their R&D capabilities in development of new plant-based vaccines. For instance, in June 2016, The Texas A&M University System (including Texas A & M University AgriLife Research and the Texas A & M Institute of Infectious Animal Diseases (IIAD)) entered into an agreement with iBio, Inc. and its subsidiary, iBio CMO LLC, for a collaborative program in plant-produced pharmaceuticals. This collaboration is expected to leverage R&D resources of the research institute with the commercial therapeutics and vaccine development, and manufacturing capabilities of iBio. Through this collaboration, their objective was to rapidly develop and test cost-effective, commercial, therapeutic, and vaccine solutions against various diseases such as influenza and Ebola.
Furthermore, in July 2013, Medicago, Inc., a Canada-based biopharmaceutical company, entered into a definitive agreement with Mitsubishi Tanabe Pharma Corporation, whereby Medicago was acquired by Mitsubishi with 60% share in Medicago, Inc. 40% of the shares are currently held by Philip Morris Investments B.V.
Request Here For PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2004
0 notes
Text
Animal Vaccines Market Future Scope, Demands and Projected Industry Growths to 2027
Market Highlights
The global animal vaccines market is expected to have a market value of USD 13,209.14 million by 2027.
The animal vaccines market suffered immensely because pet owners and farmers were encouraged to keep their animals at home. They were advised against taking their pets to the vet to get strong and effective vaccines like the Pfizer veterinary vaccines. Growth in the veterinary/animal vaccines market is starting to pick up dramatically now that a vaccine for COVID-19 is being widely administered. Demand for animal vaccines is surging because livestock on farms around the world need these to remain healthy Segment Analysis
The global animal vaccines market is segmented into type, technology, and region. The type segment is further segmented into porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquacultutre vaccines. The technology segment is segmented into Live attenuated vaccines, Inactivated vaccines, Toxoid vaccines, Recombinant vaccines, others.
Regional Analysis
The global palliative care market, based on region, has been divided into Americas, Europe, Asia-Pacific, and Middle East & Africa.
Americas dominated the global animal vaccine market due to various factors, such as the rising prevalence of animal diseases and the rise in pet ownership in the region. Furthermore, the high number of veterinary clinics in the region also boosts the growth of the market. There is an increasing prevalence of animal diseases such as foot & mouth disease, canine parvovirus, distemper, and reproductive & respiratory syndrome. Parvovirus infections are seen across the US and Canada. The American Veterinary Medical Association (AVMA) reported around 118,624 veterinary practitioners were operating in 2020. Similarly, according to the statistics published by the Canadian Veterinary Medical Association in 2020, about 12,921 veterinarians were present in Canada.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7184
Europe accounted for a significant share in the market owing to a high population of companion animals in Europe, rising research and development investment, and increasing adoption of animal vaccines. According to the Industrial Association of Pet Care Producers, there are around 34 million pets in the UK, including dogs, cats, small mammals, and birds. In October 2021, Boehringer Ingelheim announced an additional 100 million EUR investment in its veterinary public health capabilities in Lyon-Jonage, France, to aid governments and public health organizations in managing future emerging and transboundary diseases. The additional investment will enable the adaptation of production lines for other emerging diseases, in particular swine and avian vaccines.
Asia-Pacific is expected to exhibit the highest CAGR during the forecast period of 2021-2027. This is due to lucrative opportunities for players operating in the animal vaccine market, a rise in the livestock population, and the increasing prevalence of animal diseases in the region. There is increasing awareness about animal health in the Asia-Pacific region. For instance, according to the report published by Pet Fair Asia and goumin.com, the total number of pet dogs and cats in China reached 99.15 million, with pet owners spending 29 billion US dollars in 2019. The increasing prevalence of animal diseases such as foot and mouth disease and avian influenza boosts the market growth in the region.
Middle East & Africa is expected to witness restricted growth compared to other regions due to limited access and healthcare affordability. The market growth in the region is driven by factors like the increasing incidence of zoonotic diseases and increasing pet adoption in the region. The common zoonotic disease diagnosed in this region is Rift Valley fever. Hence, emphasis is being put on promoting animal health in the region and improving healthcare services for companion animals.
Key Findings of the Study
The global animal vaccines market is estimated to reach USD 13,209.14 million by 2027 at a CAGR of 7.48 % during the assessment period.
Americas accounted for the largest share of the global animal vaccines market due to the rising prevalence of animal diseases and the rise in pet ownership in the region.
Based on type, the companion animal vaccines segment accounted for the largest market share of 42.2% in 2020.
By technology, the live attenuated vaccines segment accounted for the largest market share of 62.02% in 2020.
Some of the key players operating in the animal vaccines market are Boehringer Ingelheim International GmbH (Germany), Zoetis Inc. (US), Ceva Santé Animale (France), Merck & Co., Inc. (US), Elanco Animal Health Incorporated (US), Virbac (France), Phibro Animal Health Corporation (US), Hipra (Spain), Biogénesis Bagó S.A.(Argentina), Neogen Corporation (US).
Browse Detailed TOC with COVID-19 Impact Analysis at
https://www.marketresearchfuture.com/reports/animal-vaccines-market-7184
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
0 notes
Text
Veterinary Vaccines Market : Emerging Trends, Business Growth Opportunities, Major Driving Factors
The research authors at Transparency Market Research have placed the evaluation of the global veterinary vaccines market at US$ 6,100 million in the year of 2017. They predict that the global veterinary vaccines market will grow at an exemplary CAGR of 6.5% over the forecast period of 2018 to 2026 and go on to hit the mark of US$ 12,000 million by the end of the forecast period in 2026. Rising spending on companion pet animals along with increasing prevalence of various animal diseases is expected to propel the growth of global veterinary vaccines market in coming years.
Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=215
Increasing prevalence of animal diseases such as rift valley fever and rotavirus, rising utilization of different types of animal vaccines, and increasing awareness regarding the availability of different types of vaccination programs in motivating the growth of the global veterinary vaccines market in coming years. Rising prevalence of avian influenza and foot and mouth disease, considered as two of the foremost trans barrier animal diseases have also fueled the requirement for enhanced products in the global veterinary vaccines market.
Request a Sample of Veterinary Vaccines Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=215
DNA Vaccines Segment to Witness High Growth in Veterinary Vaccines Market in Near Future
Segments in the global veterinary vaccines market by technology include inactivated vaccines, live attenuated vaccines, conjugate vaccines, toxoid vaccines, and DNA Vaccines, among others. Live attenuated vaccines segment led the global veterinary vaccines market in recent years, however, this segment is projected to lose momentum owing to loss of opportunities for the new industry players in this particular segment. DNA vaccines segment may witness significant growth opportunities in the global veterinary vaccines market in coming years owing to their various advantages such as no need for adjuvants as well as no post vaccination reactions.
Segments in the global veterinary vaccines market by type of animal include companion animal vaccines and livestock animal vaccines. Livestock animal vaccines segments led the global veterinary vaccines market in 2017 but is anticipated to lose market share over the forecast period owing to decreasing number of farm animals in certain regions in the world. On the other hand, increasing number of companion animals along with rising expenditure on pet healthcare are expected to boost the segment in global veterinary vaccines market over the forecast period.
Request for Analysis of COVID19 Impact on Veterinary Vaccines Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=215
North America Region Leads the Veterinary Vaccines Market
Key geographical regions covered in the professional intelligence report on the global veterinary vaccines market include North America (Canada and United States), Asia Pacific (including China, Japan, New Zealand, India, Australia, and rest of the Asia Pacific), Europe (including the United Kingdom, France, Spain, Italy, Germany, and rest of the Europe), Middle East and Africa (including South Africa, Gulf Cooperation Council countries, Israel, and rest of the Middle East and Africa), and Latin America (including Brazil, Mexico, and rest of the Latin America). Geographically, North America region held the largest share in the global veterinary vaccines market in 2017. This position in anticipated to remain in the forecast period, owing to rising ownership of companion animals and advanced vaccination programs in the region.
Enquiry before Buying Veterinary Vaccines Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=215
Players in the Veterinary Vaccines Market Expanding their Product Portfolios
Major corporate players covered in the market analysis on global veterinary vaccines market include Merck Animal Health, Eli Lilly and Company, Ceva Santé Animale, Biovac, ImmuCell Corporation, Boehringer Ingelheim GmbH, Zoetis, Inc., Bayer Animal health AG, Virbac, and Neogen Corporation. Manufacturers and players in the global veterinary vaccines market are adopting various inorganic as well as organic growth strategies to enhance their current product offerings and expand their product portfolios in order to gain a larger market share by expanding their consumer base as well as geographical reach. For example, Prondil S.A, an Uruguayan company was acquired by Merck Animal health in December of 2017 to design and produce more advanced livestock animal vaccines.
More Trending Reports by Transparency Market Research:
https://www.prnewswire.com/news-releases/human-microbiome-market-to-reach-us-2-2-bn-by-2028--states-tmr-report-301475663.html
https://www.prnewswire.com/news-releases/increase-in-prevalence-of-fascioliasis-to-help-triclabendazole-market-reach-us-632-1-mn-by-2031--notes-tmr-study-301478857.html
https://www.prnewswire.com/news-releases/medical-transcription-services-market-to-expand-at-cagr-of-5-during-forecast-period-observes-tmr-study-301482824.html
About Us Section:
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Mr. Rohit Bhisey Transparency Market Research, 90 State Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: [email protected]
Website: https://www.transparencymarketresearch.com/
0 notes